Search

Search Results
Results 17361 - 17370 of 17459 for Depression
  • Drug - 26 Jul 2022
    Consumer Medicine Information (CMI) about Natrilix SR (Sustained Release tablets containing indapamide) intended for persons living in Australia.
  • Drug - 26 Jul 2022
    Consumer Medicine Information (CMI) about Natrilix (indapamide) intended for persons living in Australia.
  • Drug - 26 Jul 2022
    Consumer Medicine Information (CMI) about Odaplix SR (Sustained Release tablets containing indapamide) intended for persons living in Australia.
  • Drug - 22 Jul 2022
    Consumer Medicine Information (CMI) about Kadcyla intended for persons living in Australia.
  • Drug - 20 Jul 2022
    Consumer Medicine Information (CMI) about Micardis (telmisartan) intended for persons living in Australia.
  • Drug - 19 Jul 2022
    Consumer Medicine Information (CMI) about Abyraz intended for persons living in Australia.
  • Drug - 13 Jul 2022
    Consumer Medicine Information (CMI) about Simponi (Golimumab) intended for persons living in Australia.
  • Drug - 4 Jul 2022
    Consumer Medicine Information (CMI) about Bupivadren intended for persons living in Australia.
  • Drug - 28 Jun 2022
    Consumer Medicine Information (CMI) about Coralan (ivabradine 5mg & 7.5mg film coated tablets) intended for persons living in Australia.
  • Drug - 27 Jun 2022
    Consumer Medicine Information (CMI) about DBL Glyceryl Trinitrate intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.